Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Molecular Medicine (Cambridge, Mass.)|January 1, 1996
The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reactionE Rosengren, R Bucala, P Aman, et al.
Molecular Medicine (Cambridge, Mass.)|January 15, 2002
Immunological detection of a novel advanced glycation end-productM Takeuchi, Y Yanase, N Matsuura, et al.
Protein Engineering|August 1, 1996
The subunit structure of human macrophage migration inhibitory factor: evidence for a trimerH W Sun, M Swope, C Cinquina, et al.
The Journal of Experimental Medicine|January 1, 1996
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reactionJ Bernhagen, M Bacher, T Calandra, et al.
Metabolism: Clinical and Experimental|June 1, 1997
Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitusT J Berg, H J Bangstad, P A Torjesen, et al.
Science (New York, N.Y.)|October 23, 1992
Hemoglobin-AGE: a circulating marker of advanced glycosylationZ Makita, H Vlassara, E Rayfield, et al.
Arthritis and Rheumatism|May 20, 1998
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritisM Leech, C Metz, L Santos, et al.
Journal of Neuropathology and Experimental Neurology|January 4, 2001
Neurotoxicity of advanced glycation end-products for cultured cortical neuronsM Takeuchi, R Bucala, T Suzuki, et al.
The American Journal of Pathology|February 1, 1997
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused ratsA W Stitt, Y M Li, T A Gardiner, et al.
Pageof 19